News Release

Northwestern University’s Dr. Susan E. Quaggin named one of seven Distinguished Scientists

American Heart Association Scientific Sessions 2022

Grant and Award Announcement

American Heart Association

Embargoed until 7 a.m. CT / 8 a.m. ET Friday, Oct. 28, 2022

DALLAS, Oct. 28, 2022 – The American Heart Association is presenting one of its 2022 Distinguished Scientist awards to Susan E. Quaggin, M.D., FAHA (Hon.), of Northwestern University. The Association honors members who have significantly advanced the understanding of cardiovascular, stroke or brain health as Distinguished Scientists. Seven 2022 Distinguished Scientist awardees will be recognized during the Association’s Scientific Sessions 2022, which will be held in person in Chicago and virtually Nov. 5-7.

Dr. Quaggin has conducted extensive research related to kidney health. Her work in molecular biology around transcription factor action within developing kidneys has helped advance transgenic mouse models used to study kidney disease. Her discoveries related to vascular endothelial growth factor led to connections between growth factor inhibition and thrombotic microangiopathy and kidney failure. Her work has inspired new protocols for renal assessments and led to new insight into pre-eclampsia. Her discoveries also are applicable to caring for patients who are at high risk for cardiovascular mortality because of kidney disease.

She is the chief of Nephrology and Hypertension and director of the Feinberg Cardiovascular and Renal Research Institute at Northwestern University Feinberg School of Medicine. Dr. Quaggin is also the Charles Horace Mayo Professor of Medicine at Northwestern University. Additionally, she is the current elected president of the American Society of Nephrology and is an elected councilor of the Association of American Physicians.

Dr. Quaggin earned a Doctor of Medicine from the University of Toronto. She completed a fellowship in nephrology at the University of Toronto and completed two post-doctoral fellowships, one in molecular biology of kidney development at the Igarashi Lab at Yale University and one in mouse genetics at the Rossant Lab at the University of Toronto.

She has published more than 120 peer-reviewed articles. Dr. Quaggin is the deputy editor of Journal of Clinical Investigation, the coeditor of Seldin and Gelbisch: The Kidney and coeditor of the pathophysiology section of Current Opinion in Nephrology and Hypertension Renal Physiology. She was previously recognized by the American Heart Association in 2012 with the Donald Seldin Lectureship Award and is an elected member of the National Academy of Medicine and the National Academy of Investigators.

Additional Resources:

The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here

The American Heart Association’s Scientific Sessions 2022 is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. The 3-day meeting will feature more than 500 sessions focused on breakthrough cardiovascular basic, clinical and population science updates occurring Saturday through Monday, November 5-7, 2022. Thousands of leading physicians, scientists, cardiologists, advanced practice nurses and allied health care professionals from around the world will convene virtually to participate in basic, clinical and population science presentations, discussions and curricula that can shape the future of cardiovascular science and medicine, including prevention and quality improvement. During the three-day meeting, attendees receive exclusive access to more than 4,000 original research presentations and can earn Continuing Medical Education (CME), Continuing Education (CE) or Maintenance of Certification (MOC) credits for educational sessions. Engage in Scientific Sessions 2022 on social media via #AHA22.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.orgFacebookTwitter or by calling 1-800-AHA-USA1.



Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.